99% Savings - Buy Just @1 Rs X
Sarot is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Sarot safe for pregnant women?
Sarot may have some side effects during pregnancy. Pregnant women should discontinue the use of Sarot, and talk to their doctor, if they notice any discomfort.
Is the use of Sarot safe during breastfeeding?
Sarot does not show any side effects in breastfeeding women.
What is the effect of Sarot on the Kidneys?
Sarot does not damage the kidneys.
What is the effect of Sarot on the Liver?
Use of Sarot may be dangerous for the liver. Do not use it without doctor's advice.
What is the effect of Sarot on the Heart?
Very few cases of side effects of Sarot on the heart have been reported.
Sarot should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Sarot unless your doctor advises you to do so -
Is this Sarot habit forming or addictive?
Sarot is not addictive in nature.
Interaction between Food and Sarot
Taking Sarot with food is safe.
Interaction between Alcohol and Sarot
Taking alcohol with Sarot can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 900
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nizoral (ketoconazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792-793
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177